NET

The candidate must have a M.S, M.Pharm, degree in Medicinal chemistry, Natural Products, Pharmaceutical Analysis from a PCI, AICTE, UGC, NAAC recognized, accredited University, Central Autonomous Institutes with 60% marks or above.

To delineate the survival strategy of mycobacteria through antigenic determinants by inhibiting autophagy via miRNA and its significance in host directed therapy 

Master Degree in Pharmaceutical Sciences First-class with GPAT qualification Preferably in Pharmaceutics from a recognized University. developing nanoformulations, mammalian cell cultures, and in vivo experiments. Synthesis of Polymers, peptides Characterization of physicochemical Parameter, Determination of anticancer therapeutic effect in the in vitro assay systems, Validation of the in vitro results in the in vivo animal models of tumor-bearing mice model and infectious disease models

M.Sc, BTech in Bio, Chemo, Pharmaco-informatics from a recognised university or Research experience in computational drug discovery. Knowledge of AI/ML would be an added advantage.

BTech, MTech in Biotechnology, Biomedical Engineering, Mechanical Engineering, Chemical Engineering, Polymer Engineering, Materials Engineering or relevant discipline; M.Pharm, MS in Pharmacy, or MSc in Biotechnology, Biochemistry, Zoology, Microbiology, Chemistry

BS 4 years programme, BPharm, MBBS, BVSc, Integrated BS-MS, MSc, BE, BTech or equivalent degree, with 55% marks and passing of NET, GATE test.

M.Pharm from a recognized University or Equivalent and 4 years R&D Experience in industrial and academic institutions or science and technology organisations. OR Phd in Pharmaceuticals from a recognized University or Equivalent. Specializing in Pharmacognosy, Natural Products.

Can β-glucan-induced gut microbiome metabolites improve PCOS symptoms? An experimental and clinical study. MSc. in any branch of biological sciences from any reputed university, institute. Should be qualified any national level examination such as NET, GATE qualified